← Back to Search

Care Ecosystem for Dementia

N/A

Recruiting

Led By Katherine L Possin, PhD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Have a dementia diagnosis documented in the EHR

Age 18+

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline to 12 months

Awards & highlights

Study Summary

This trial will evaluate how an accessible, team-based dementia care program can improve outcomes for patients, caregivers, and healthcare providers during the pandemic.

Who is the study for?

This trial is for adults with various types of progressive dementia, including Alzheimer's, who live at home and have a primary caregiver willing to participate. They must not be in long-term care facilities, should agree to join the Care Ecosystem program and complete surveys. Those previously enrolled in the program or without accessible health records are excluded.Check my eligibility

What is being tested?

The study tests the 'Care Ecosystem,' a remote care model delivered by phone and web designed to support patients with dementia and their caregivers. It aims to improve patient quality of life, reduce emergency visits, lower caregiver depression, and cut inappropriate medication use.See study design

What are the potential side effects?

Since this intervention involves non-medical support rather than drugs or medical procedures, traditional side effects aren't expected. However, there may be indirect impacts on stress levels or emotional well-being that will be monitored.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My medical records show a dementia diagnosis.

Select...

I am 18 years old or older.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline to 12 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline to 12 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to 12 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in caregiver depression

Change in emergency department (ED) visits

Change in potentially inappropriate medications for dementia or cognitive impairment

+1 more

Secondary outcome measures

Change in PWD annual bed days

Change in PWD hospitalizations

Change in caregiver anxiety

+3 more

Other outcome measures

Modifications of anti-dementia medications

Trial Design

1Treatment groups

Experimental Treatment

Group I: Care EcosystemExperimental Treatment1 Intervention

Patient and caregiver dyads receive the Care Ecosystem intervention

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Care Ecosystem

2020

N/A

~530

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Institute on Aging (NIA)NIH

1,672 Previous Clinical Trials

28,016,113 Total Patients Enrolled

University of California, San FranciscoLead Sponsor

2,505 Previous Clinical Trials

15,235,005 Total Patients Enrolled

Ochsner Health SystemOTHER

93 Previous Clinical Trials

182,111 Total Patients Enrolled

Media Library

Care Ecosystem Clinical Trial Eligibility Overview. Trial Name: NCT05669365 — N/A

Alzheimer's Dementia Research Study Groups: Care Ecosystem

Alzheimer's Dementia Clinical Trial 2023: Care Ecosystem Highlights & Side Effects. Trial Name: NCT05669365 — N/A

Care Ecosystem 2023 Treatment Timeline for Medical Study. Trial Name: NCT05669365 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many venues is this trial conducted in?

"Currently, this trial is accepting participants across 6 locations including Torrence, Denver and New Orleans. To reduce travel expenses associated with enrolling in the study, it's recommended to select a clinic closest to you."

Answered by AI

Are there any vacancies available for participants in this experiment?

"Reports on clinicaltrials.gov reveal that, at present, this medical trial is not looking for participants. The study was initially posted on January 1st 2023 and recently amended December 20th 2022. However, there are countless other studies still inviting applications with 799 trials actively recruiting patients currently."

Answered by AI

What outcomes is this research hoping to demonstrate?

"As the primary outcome, this clinical trial will measure a Change in Caregiver Depression over the 12-month period. Secondary outcomes include Change in PWD Annual Bed Days, CNS Acting Medications, and Caregiver Burden - all of which are evaluated according to established criteria outlined by Peipert et al., 2018."

Answered by AI

Recent research and studies

JAMA Internal MedicineJournal

Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use

Possin, Katherine L., Jennifer J. Merrilees, Sarah Dulaney, Stephen J. Bonasera, Winston Chiong, Kirby Lee, Sarah M. Hooper, et al.. 2019. “Effect of Collaborative Dementia Care via Telephone and Internet on Quality of Life, Caregiver Well-being, and Health Care Use”. JAMA Internal Medicine. American Medical Association (AMA). doi:10.1001/jamainternmed.2019.4101.

clinicaltrials.govStudy

The Care Ecosystem Consortium Effectiveness Study

2023. "The Care Ecosystem Consortium Effectiveness Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05669365.

All > Semantic Dementia > Frontotemporal Dementia